BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33728331)

  • 1. LC-MS/MS-Based Quantitative Proteomics Analysis of Different Stages of Non-Small-Cell Lung Cancer.
    Zhou M; Kong Y; Wang X; Li W; Chen S; Wang L; Wang C; Zhang Q
    Biomed Res Int; 2021; 2021():5561569. PubMed ID: 33728331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration of differentially expressed plasma proteins in patients with lung adenocarcinoma using iTRAQ-coupled 2D LC-MS/MS.
    Li W; Zheng H; Qin H; Liu G; Ke L; Li Y; Li N; Zhong X
    Clin Respir J; 2018 Jun; 12(6):2036-2045. PubMed ID: 29363881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung cancer serum biomarker discovery using glycoprotein capture and liquid chromatography mass spectrometry.
    Zeng X; Hood BL; Sun M; Conrads TP; Day RS; Weissfeld JL; Siegfried JM; Bigbee WL
    J Proteome Res; 2010 Dec; 9(12):6440-9. PubMed ID: 20931982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics analysis of human serum of patients with non-small-cell lung cancer reveals proteins as diagnostic biomarker candidates.
    Boccellino M; Pinto F; Ieluzzi V; Giovane A; Quagliuolo L; Fariello C; Coppola M; Carlucci A; Santini M; Ferati K; Bexheti-Ferati A; Giordano A; Di Domenico M
    J Cell Physiol; 2019 Dec; 234(12):23798-23806. PubMed ID: 31180588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Serological Early Biomarker Candidates for Lung Adenocarcinoma by using Multiple Reaction Monitoring-Mass Spectrometry.
    Wu HY; Pan YY; Kopylov AT; Zgoda V; Ma MC; Wang CH; Su WC; Lai WW; Cheng PN; Liao PC
    Proteomics Clin Appl; 2020 Jul; 14(4):e1900095. PubMed ID: 32012456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Human Epididymis Secretory Protein 4 (HE4) is a Potential Prognostic Biomarker in Non-Small Cell Lung Cancer.
    Mo D; He F
    Clin Lab; 2018 Sep; 64(9):1421-1428. PubMed ID: 30274019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative proteomic analysis of non-small-cell lung cancer and normal controls using serum label-free quantitative shotgun technology.
    Pan J; Chen HQ; Sun YH; Zhang JH; Luo XY
    Lung; 2008; 186(4):255-261. PubMed ID: 18465169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and Validation of Predictive Biomarkers of Survival for Non-small Cell Lung Cancer Patients Undergoing Radical Radiotherapy: Two Proteins With Predictive Value.
    Walker MJ; Zhou C; Backen A; Pernemalm M; Williamson AJ; Priest LJ; Koh P; Faivre-Finn C; Blackhall FH; Dive C; Whetton AD
    EBioMedicine; 2015 Aug; 2(8):841-50. PubMed ID: 26425690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach.
    Beretov J; Wasinger VC; Millar EK; Schwartz P; Graham PH; Li Y
    PLoS One; 2015; 10(11):e0141876. PubMed ID: 26544852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung cancer serum biomarker discovery using label-free liquid chromatography-tandem mass spectrometry.
    Zeng X; Hood BL; Zhao T; Conrads TP; Sun M; Gopalakrishnan V; Grover H; Day RS; Weissfeld JL; Wilson DO; Siegfried JM; Bigbee WL
    J Thorac Oncol; 2011 Apr; 6(4):725-34. PubMed ID: 21304412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
    Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
    Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification a novel clinical biomarker in early diagnosis of human non-small cell lung cancer.
    Jin Y; Yang Y; Su Y; Ye X; Liu W; Yang Q; Wang J; Fu X; Gong Y; Sun H
    Glycoconj J; 2019 Feb; 36(1):57-68. PubMed ID: 30607521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Proteomics-based identification of proapoptotic caspase adapter protein as a novel serum marker of non-small cell lung cancer].
    Zhang H; Chen S; Huang L
    Zhongguo Fei Ai Za Zhi; 2012 May; 15(5):287-93. PubMed ID: 22613335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
    Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
    Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systems biology analysis of the lung cancer‑related secretome.
    Feng L; Yang Y; Li M; Song J; Gao Y; Cheng S; Xiao T
    Oncol Rep; 2018 Aug; 40(2):1103-1118. PubMed ID: 29989649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Monitoring and Phenotype Identification of Stage I Non-Small Cell Lung Cancer Patients.
    Hocker JR; Deb SJ; Li M; Lerner MR; Lightfoot SA; Quillet AA; Hanas RJ; Reinersman M; Thompson JL; Vu NT; Kupiec TC; Brackett DJ; Peyton MD; Dubinett SM; Burkhart HM; Postier RG; Hanas JS
    Cancer Invest; 2017 Oct; 35(9):573-585. PubMed ID: 28949774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of biomarkers of therapeutic effects of patients with lung adenocarcinoma treated with gefitinib based on progression-free-survival by metabolomic fingerprinting.
    Zhuang J; Tang X; Du Z; Yang M; Zhou Y
    Talanta; 2016 Nov; 160():636-644. PubMed ID: 27591660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers.
    Li BT; Lou E; Hsu M; Yu HA; Naidoo J; Zauderer MG; Sima C; Johnson ML; Daras M; DeAngelis LM; Fleisher M; Kris MG; Azzoli CG
    PLoS One; 2016; 11(1):e0146063. PubMed ID: 26730601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an AlphaLISA assay to quantify serum core-fucosylated E-cadherin as a metastatic lung adenocarcinoma biomarker.
    Wen CL; Chen KY; Chen CT; Chuang JG; Yang PC; Chow LP
    J Proteomics; 2012 Jul; 75(13):3963-76. PubMed ID: 22634079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preliminary Study on the Biological Markers for I-IIb Stage Non-small Cell Lung Cancer Based on a Serum-peptidomics].
    Hou Y; Guo H; Guo Y; Zhang Y; Han H
    Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):20-25. PubMed ID: 30674389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.